Fig. 7
From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway
Tumor formation in the K562/si-FAM168A mice and K562/Control mice. a Schematic representation of a mouse in the PBS Control group. There was no tumor mass in the PBS Control mice. b Schematic representation of a mouse in the K562/Control group. The tumors are indicated by the red arrows. c The tumor volume in K562/si-FAM168A group and K562/Control group. NS: non-significant